fbpx

2 Texas Firms Get $42M Patent Verdict Against Boston Scientific in Delaware

A jury in Delaware federal court found Boston Scientific’s SYNERGY stents were derived from information given to the company executives both in person at a conference and again via email exchanges.

       

Related Articles

Responses

Your email address will not be published. Required fields are marked *